LB Pharmaceuticals Inc (NasdaqGM: LBRX)
Health Care · Pharmaceuticals · US
$34.61
-6.43% today · +144.3% 1Y
LB Pharmaceuticals Inc (NasdaqGM: LBRX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.19B and employs 49 people.
Over the last twelve months the share price has gained 144.3%, trading between 13.40 and 50.16.
Tweenvest scores LB Pharmaceuticals Inc across four factors: quality 52/100, value 45/100. Its strongest factor is quality.
LBRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.19B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.81
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $50.16
- 52-week low
- $13.40
- Avg volume (3M)
- —
- Shares outstanding
- 32.26M
- Employees
- 49
- Next earnings
- —
About LB Pharmaceuticals Inc
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
- ISIN
- US50180M1080
- Founded
- 2015
- Listed since
- Sep 11, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aurisco Pharmaceutical Co.,Ltd.SHSE: 605116 | $1.21B | CN¥20.07 | +2.40% |
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.20B | CN¥39.40 | -1.38% |
| Sichuan Huiyu Pharmaceutical Co., Ltd.SHSE: 688553 | $1.19B | CN¥12.85 | +4.81% |
| Cronos Group Inc.TSX: CRON | $1.19B | CA$4.58 | -0.87% |
| Wanbangde Pharmaceutical Holding Group Co., Ltd.SZSE: 002082 | $1.18B | CN¥12.97 | +8.08% |
| Zhejiang Tianyu Pharmaceutical Co., Ltd.SZSE: 300702 | $1.17B | CN¥22.68 | +6.48% |
| Sawai Group Holdings Co., Ltd.TSE: 4887 | $1.17B | ¥1,589.00 | -4.65% |
| Beijing Foyou Pharma CO.,LTDSHSE: 601089 | $1.15B | CN¥16.48 | +3.78% |
Figures last refreshed Oct 4, 2026.